Janis Liebetanz

In vivo antitumor activity of NVP-AEW541—A novel, potent, and selective inhibitor of the IGF-IR kinase

Carlos Garcı́a-Echeverrı́a, Mark Pearson, Andreas Marti et al. · Cancer Cell · 2004 · 535 citations · Full text

Cancer Research, Medicine, Receptor Tyrosine Kinase +9

The Crystal Structure of a c-Src Complex in an Active Conformation Suggests Possible Steps in c-Src Activation

Sandra W. Cowan‐Jacob, Gabriele Fendrich, Paul W. Manley et al. · Structure · 2005 · 341 citations · Full text

Crystal Structure, Biochemistry, C-src Activation +8

Structural biology contributions to the discovery of drugs to treat chronic myelogenous leukaemia

Sandra W. Cowan‐Jacob, Gabriele Fendrich, Andreas Floersheimer et al. · Acta Crystallographica Section D Biological Crystallography · 2006 · 282 citations · Full text

Imatinib-resistant Patients, Mutant Abl Kinase, Hematological Malignancy +12

Extended kinase profile and properties of the protein kinase inhibitor nilotinib

Paul W. Manley, Peter Drueckes, Gabriele Fendrich et al. · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · 2009 · 218 citations

Drug Target, Medicine, Receptor Tyrosine Kinase +8

Src Phosphorylation of the Epidermal Growth Factor Receptor at Novel Sites Mediates Receptor Interaction with Src and P85α

David R. Stover, Michael Becker, Janis Liebetanz et al. · Journal of Biological Chemistry · 1995 · 214 citations · Full text